Clinical trial
S9415 Chemotherapy in Patients With Stage II or III Colon Cancer That Has Been…
NCT00002593 · SWOG Cancer Research Network, Other · Completed
Key facts
| NCT number | NCT00002593 |
|---|---|
| Title | S9415 Chemotherapy in Patients With Stage II or III Colon Cancer That Has Been Surgically Removed |
| Official title | Phase III Randomized Trial of 5-FU/Leucovorin/Levamisole Versus 5-FU Continuous Infusion/Levamisole as Adjuvant Therapy for High-Risk Resectable Colon Cancer |
| Lead sponsor | SWOG Cancer Research Network, Other |
| Collaborators | National Cancer Institute (NCI) NIH Cancer and Leukemia Group B Eastern Cooperative Oncology Group North Central Cancer Treatment Group |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Colorectal Cancer |
| Intervention type | Drug |
| Interventions | fluorouracil, leucovorin calcium, levamisole hydrochloride |
| Enrollment | 1,135 |
| Start date | Dec 1, 1994 |
| Primary completion | Dec 1, 1999 |
| Completion | Mar 1, 2005 |
| First posted | Aug 31, 2004 |
| Last update posted | Jan 3, 2013 |
| Countries | Canada, Puerto Rico, South Africa, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: